BEVERLY HILLS
A torn rotator cuff that never quite heals. Knee cartilage that grinds a little more each year. Chronic tendon pain that physical therapy improves but does not resolve. These are the injuries that send patients searching for something beyond cortisone shots and pain medication.
Regenerative orthopedic treatment uses concentrated biologic agents, including platelets, stem cells, and growth factors, to repair damaged musculoskeletal tissue rather than mask symptoms. This article covers how these therapies work, which conditions they treat, what the evidence actually supports, and how to determine whether you might be a candidate.
Regenerative orthopedic treatment uses your body’s own healing mechanisms to repair damaged muscles, tendons, ligaments, and cartilage. Rather than masking pain with steroid injections or long-term medication, these therapies concentrate biologic agents (platelets, stem cells, growth factors) and reintroduce them directly into injured tissue. The goal is actual tissue repair, not temporary symptom relief.
Think of it this way: a cortisone shot can quiet inflammation for a few months, but it does nothing to heal a torn rotator cuff or worn knee cartilage. Regenerative treatment takes a different approach by giving your body the raw materials it needs to rebuild damaged structures.
When concentrated biologics are injected into an injury site, they release proteins that tell your body to start repairing. These signaling molecules do a few things at once: they attract repair cells to the area, calm down chronic inflammation, and promote angiogenesis (the formation of new blood vessels that bring oxygen and nutrients to healing tissue).
Here’s what happens at the cellular level:
This is why rehabilitation matters so much after a regenerative injection. The injection provides the biological spark, while physical therapy ensures the healing tissue gets loaded and strengthened properly. One without the other often falls short.
Several biologic therapies fall under the regenerative orthopedic umbrella. Each has a different source, preparation method, and evidence base.
PRP is the most common regenerative orthopedic treatment. Your provider draws a small blood sample, spins it in a centrifuge to concentrate the platelets, then injects that concentrate into the injured tissue. Platelets contain growth factors that stimulate repair. The whole process usually takes less than an hour.
BMAC comes from your bone marrow, typically drawn from the back of your pelvis. It contains mesenchymal stem cells (cells that can develop into bone, cartilage, and other tissues) along with growth factors. The aspiration requires local anesthesia and is more involved than a blood draw, but it provides a richer concentration of regenerative cells.
Adipose-derived cells come from your own fat tissue through a minor lipoaspiration procedure. Umbilical cord blood products, on the other hand, come from donors and arrive pre-processed. The distinction between autologous (your own cells) and allogeneic (donor cells) matters for both regulatory and biological reasons.
Exosomes are tiny particles released by cells that carry signaling molecules. This is a newer area within regenerative orthopedics, with ongoing research into how these particles might enhance tissue repair.
| Treatment | Source | Contains |
Preparation |
| PRP | Patient’s blood | Platelets, growth factors |
Blood draw, centrifuge |
| BMAC | Patient’s bone marrow | Stem cells, growth factors |
Bone marrow aspiration |
| Adipose stem cells | Patient’s fat tissue | Stem cells |
Lipoaspiration |
| Umbilical products | Donor umbilical cord | Growth factors, cytokines |
Pre-processed |
Regenerative treatments are used for joint, tendon, ligament, and cartilage conditions. They tend to be most helpful when conservative care (rest, physical therapy, anti-inflammatory medication) has not provided lasting relief.
Osteoarthritis involves cartilage breakdown and joint inflammation. Regenerative therapy aims to reduce pain and support the remaining joint tissue, potentially delaying the need for joint replacement. The knee is the most commonly treated joint, though hip and shoulder osteoarthritis respond to these treatments as well.
Tendinopathy refers to chronic tendon degeneration that fails to heal with rest alone. Common sites include the Achilles tendon, rotator cuff, patellar tendon, and lateral elbow (tennis elbow). Partial tears, where some tendon fibers remain intact, are often good candidates for regenerative treatment.
Ligament injuries that do not heal fully can leave a joint unstable. The ACL, MCL, and ankle ligaments are frequent candidates for regenerative support, particularly when surgery is not desired or when a partial tear might heal with biologic assistance.
Cartilage has limited blood supply, which makes self-repair difficult. Meniscus tears and focal cartilage defects from sports trauma or repetitive stress often respond poorly to rest alone. Regenerative injections aim to support whatever healing capacity the tissue has.
The facet joints in your spine can develop arthritis just like your knee or hip. Regenerative injections may be used alongside spinal care approaches like decompression therapy, particularly when facet-related pain has not responded to other conservative treatments.
Choosing between these options depends on the condition being treated, its severity, and the tissue involved.
PRP has the most published research and is appropriate for many tendon conditions and mild to moderate joint problems. BMAC provides a higher concentration of stem cells and may be considered for more advanced joint degeneration or cartilage injuries. Stem cell therapy from adipose or umbilical sources varies widely in preparation and evidence base.
Your provider can help determine which option fits your specific situation after a thorough evaluation. The right choice often depends on factors like your age, the severity of tissue damage, and your goals for treatment.
This is the question everyone wants answered, and honesty matters here.
Current evidence shows regenerative therapies can reduce pain and improve function in many patients. Whether they produce true structural regeneration (new cartilage, rebuilt tendon fibers) remains under investigation. Some imaging studies have shown improvements in tissue quality after treatment, while others have not.
Outcomes depend on condition severity, patient health, and the specific tissue involved. A 55-year-old with bone-on-bone knee arthritis will likely have different results than a 30-year-old athlete with a partial tendon tear. The realistic expectation is meaningful pain relief and functional improvement for appropriate candidates, with the possibility (not guarantee) of tissue-level healing.
Patient selection matters for outcomes. Regenerative therapy tends to work best for people who fit certain profiles:
Overall health also plays a role. Certain conditions (uncontrolled diabetes, active infection, some autoimmune diseases) may affect eligibility. A thorough evaluation helps determine whether regenerative treatment makes sense for your specific situation.
Most regenerative procedures are completed in a single outpatient visit. Here’s how the process typically unfolds.
Your provider reviews your medical history, performs a physical examination, and may use MRI or ultrasound to assess the injury site. Accurate diagnosis before treatment is essential because regenerative therapy works best when the target tissue is clearly identified.
For PRP, blood is drawn from your arm. For BMAC, bone marrow is aspirated from your pelvis under local anesthesia. Samples are then processed in a centrifuge to concentrate the biologic material. This step usually takes 15–30 minutes.
The concentrated biologic is injected into the injured tissue using ultrasound or fluoroscopic guidance. Image guidance ensures precise placement at the target site, which matters for both safety and effectiveness.
Most patients begin rehabilitation or physical therapy within days to weeks. Activity restrictions vary by condition, but the goal is progressive loading of the healing tissue. The injection provides the biological stimulus; rehabilitation ensures the tissue develops appropriate strength and function.
Recovery varies by treatment type and condition. Most patients can resume daily activities within a few days, though high-impact exercise is typically avoided for several weeks.
Rehabilitation is part of the recovery process, not an optional add-on. The timeline for returning to sport depends on the specific injury, the treatment used, and how your body responds. Your provider and physical therapist can give you a more specific timeline based on your situation.
PRP and BMAC using your own cells are legal and widely practiced, but the FDA has not approved specific regenerative products for orthopedic indications. This means these treatments are considered “off-label” uses of your own biologic material.
Safety profiles are generally favorable. The most common side effects are injection site pain and swelling, which typically resolve within days. Because the biologics come from your own body, allergic reactions are rare.
Controlled trials are ongoing, and evidence quality varies by condition. PRP for tennis elbow and knee osteoarthritis has more supporting data than, say, exosome therapy for cartilage regeneration. When evaluating any regenerative treatment, it helps to ask your provider about the specific evidence for your condition.
Most regenerative orthopedic treatments are not covered by insurance and are paid out of pocket. Costs vary by treatment type, provider, and location. PRP is generally less expensive than BMAC, which is less expensive than stem cell therapy.
Ask for detailed pricing before proceeding, and verify coverage with your insurer if you have questions. Some providers offer payment plans or financing options.
Not all providers offering regenerative treatments have equivalent training or equipment. Here’s what to look for:
The number of injections depends on the condition being treated and your response to the initial treatment. Your provider will recommend a plan after evaluating your progress, though many patients see improvement after one or two treatments.
Regenerative injections are sometimes used alongside other conservative therapies like extracorporeal shockwave therapy or spinal decompression. Combining treatments can address different aspects of healing, particularly for complex conditions.
Age alone does not disqualify someone from regenerative treatment. Overall health and the severity of joint degeneration are considered during evaluation, but many older adults are good candidates.
Patients who have had prior surgery may still be candidates depending on the current condition of the joint. A thorough evaluation will determine appropriateness.
Timing depends on the injury type. Some acute injuries benefit from initial rest and conservative care before regenerative options are considered, while others may be treated earlier in the healing process.
At Beverly Hills Spine and Rehabilitation, regenerative orthopedic treatment begins with accurate diagnosis. Dr. Amin Javid evaluates each patient’s condition using detailed examination and imaging before recommending any intervention. Regenerative injections are performed with image guidance for precise placement, and treatment plans integrate rehabilitation to optimize outcomes.
The practice collaborates with orthopedic and spine specialists when needed, ensuring patients receive the most appropriate care for their specific condition. Regenerative therapy is one component of a broader approach that includes spinal decompression, shockwave therapy, and other conservative options for patients seeking alternatives to surgery.